Gritstone Oncology Inc (NASDAQ:GRTS)

6.75
Delayed Data
As of May 22
 +0.35 / +5.47%
Today’s Change
5.42
Today|||52-Week Range
12.96
-24.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$250.8M

Company Description

Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

Contact Information

Gritstone Oncology, Inc.
5959 Horton Street
Emeryville California 94608
P:(510) 871-6100
Investor Relations:

Employees

Shareholders

Individual stakeholders33.33%
Mutual fund holders25.34%
Other institutional24.49%

Top Executives

There are no executives to display.